Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 114 mg (equivalent: nicotine, qty 21 mg/24 h) - drug delivery system, transdermal - excipient ingredients: polyethylene; ethylene dioleamide; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 78 mg (equivalent: nicotine, qty 14 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyethylene; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 36 mg (equivalent: nicotine, qty 7 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyisobutylene; ethylene/vinyl acetate copolymer; polyethylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.